This Miami Lawyer's Blood Could Save Lives, but No One's Accepting It After His COVID-19 Recovery
After three weeks of little to no responses from nonprofit organizations, Miami lawyer Daniel Dolan said he and two friends are still trying to donate blood plasma that could help critically ill COVID-19 patients get well.
April 20, 2020 at 03:21 PM
6 minute read
When Miami lawyer Dan Dolan of Dolan Dobrinsky Rosenblum Bluestein recovered from a mild case of COVID-19, his first instinct was to donate convalescent plasma, which the Food and Drug Administration says can contain antibodies able to help seriously ill patients fight off the disease.
But after three weeks, he's still trying to donate.
Aside from receiving confirmatory emails or requests for paperwork after signing up with the American Red Cross and OneBlood, Dolan said it's been radio silence.
"There's never been a call, an email, a text or a smoke signal from anybody who said, 'Go here, go now and give blood,' " he said. "Even where I was able to identify a current patient in a hospital with a specific ID number related to transfusion, I have still not been permitted to give one drop of blood."
While the American Red Cross has yet to get back to Dolan about donating, he said a local hospital contacted him Friday about his OneBlood application to ask about donating plasma for a patient who was septic and critically ill.
"I was asked to submit my paperwork for a third time to the same blood bank," Dolan said. "And when I asked what time they wanted me to come in and donate, I was told without even a hint of urgency, that 'Maybe Monday, you should get a call.' "
Since then, OneBlood has rejected Dolan's offer to donate, saying his labs didn't fit the U.S. Food and Drug Administration's donation protocols. He's been invited to reapply and might be able to donate in two weeks.
The hospital reportedly found another donor for the critically ill patient, according to Dolan, who volunteered for a blood test Monday to supply additional data.
The FDA's website encourages anyone eligible, who has been COVID-19-free for at least two weeks, to donate plasma.
"Individuals must have had a prior diagnosis of COVID-19 documented by a laboratory test and meet other donor criteria," the FDA's website says. "Individuals must have complete resolution of symptoms for at least 28 days before they donate, or alternatively have no symptoms for at least 14 days prior to donation and have a negative lab test for active COVID-19 disease."
Though Dolan had his last symptom March 21, OneBlood reportedly said it would prefer a few more weeks. Dolan also registered with the National COVID-19 Convalescent Plasma Project but received no response.
|'Odd-feeling illness'
Generally fit and healthy, Dolan hadn't had a cold in years — until March 14, when he started feeling what he thought was a minor cough and scratchy throat. It was thankfully a mild case of the virus, which he described as "an odd-feeling illness" because of its "rhythmic nature."
"The waxing and waning of the symptoms was hallmark for this, where you feel sick one day and the next day you feel better and you think to yourself, 'It's over,' and then you get hit again that night with more fever," Dolan said.
Dolan quarantined himself and was ill for about eight days, with the worst symptoms being severe body pains and aches for about three days. He didn't experience any respiratory issues, and it took several days to get test results back, so Dolan only discovered he had COVID-19 after he had recovered.
Two of Dolan's friends fell ill around the same time and were hospitalized but have now recovered. They have also tried multiple times to donate plasma to no avail.
"Not one of us has been able to navigate our way through this infrastructure to be able to donate, and I don't have an explanation for it," Dolan said.
|Why the delay?
Dolan said he doesn't aim to disparage or blame the organizations during a time of crisis but rather wants to understand what's happening behind the scenes.
"It's either that the need is not as great as it appears to be, although I don't know if that's true because there were people that had a need and I was not able to fill that need for them," Dolan said. "Or, No. 2, there's some infrastructure barrier to facilitating the donation and turning it into care that is not being addressed."
American Red Cross spokesperson Stephanie Rendon said the FDA has asked it to help identify prospective donors and manage distribution to hospitals through its new COVID-19 website.
"We understand the urgency and that there are patients who are in need and we are committed to facilitating and distributing convalescent blood donations," Rendon said. "So far, thousands of potential donors have responded to our call to help patients seriously ill with active COVID-19 infections. Unfortunately, fewer than half of these individuals have a documented confirmed diagnosis of COVID-19 required by the FDA. Additionally, in order to be determined as eligible to participate in the COVID-19 convalescent plasma program donors also must confirm their last day of any COVID-19 symptom was 28 days prior to donation or confirm they have been completely symptom-free 14 days prior to donation and provide a negative COVID-19 test result."
OneBlood did not respond to a request for comment by deadline. Its President and CEO George "Bud" Scholl has said in a press release that Miami Mayor Francis Suarez became Florida's first donor April 3, and that OneBlood has worked "around-the-clock in order to implement the new FDA protocols to begin collecting COVID-19 convalescent plasma."
Dolan also registered with the National COVID-19 Convalescent Plasma Project weeks ago but hasn't heard back. According to its Florida media relations team, that could be because the study only began Monday. One team member, Tracy Thompson, said the project is a grassroots effort.
"We are seeing new sites come online every day and getting multiple requests for information every day," Thompson said via email. "We are sharing the contact information of potential donors with confirmed doctors who are trying to collect convalescent plasma. Because of the lack of testing, this has been a difficult process."
Read more:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllFla.'s Statute of Limitations and Statutes of Repose in Med Mal Cases: It's Not Over Until It's Over
6 minute readGC of Florida State Agency Steps Down After Threatening TV Stations That Aired Abortion-Rights Ad
Trending Stories
- 1Risk & Reward
- 2On The Move: Polsinelli Adds Health Care Litigator in Nashville, Ex-SEC Enforcer Joins BCLP in Atlanta
- 3After Mysterious Parting With Last GC, Photronics Fills Vacancy
- 4Latham Lures Restructuring Partners From Weil, Paul Weiss
- 5Haynes Boone, Hicks Thomas Get Dismissal of $1.3B Claims in 2022 Freeport LNG Terminal Explosion
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250